PL322409A1 - Reversible protease inhibitors - Google Patents
Reversible protease inhibitorsInfo
- Publication number
- PL322409A1 PL322409A1 PL96322409A PL32240996A PL322409A1 PL 322409 A1 PL322409 A1 PL 322409A1 PL 96322409 A PL96322409 A PL 96322409A PL 32240996 A PL32240996 A PL 32240996A PL 322409 A1 PL322409 A1 PL 322409A1
- Authority
- PL
- Poland
- Prior art keywords
- protease inhibitors
- reversible protease
- reversible
- inhibitors
- protease
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 230000002441 reversible effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/6533—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40999695A | 1995-03-24 | 1995-03-24 | |
PCT/US1996/003844 WO1996030353A1 (en) | 1995-03-24 | 1996-03-21 | Reversible protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
PL322409A1 true PL322409A1 (en) | 1998-01-19 |
Family
ID=23622800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL96322409A PL322409A1 (en) | 1995-03-24 | 1996-03-21 | Reversible protease inhibitors |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0817778A1 (ko) |
JP (1) | JPH11503417A (ko) |
KR (1) | KR19980703261A (ko) |
CN (1) | CN1071751C (ko) |
AU (1) | AU713492B2 (ko) |
CA (1) | CA2216151A1 (ko) |
CZ (1) | CZ298197A3 (ko) |
IL (1) | IL117638A0 (ko) |
MY (1) | MY113489A (ko) |
NO (1) | NO311573B1 (ko) |
NZ (1) | NZ305626A (ko) |
PL (1) | PL322409A1 (ko) |
TW (1) | TW470750B (ko) |
WO (1) | WO1996030353A1 (ko) |
ZA (1) | ZA962336B (ko) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2251714A1 (en) | 1996-04-22 | 1997-10-30 | Massachusetts Institute Of Technology | Suppression of immune response via inhibition of cathepsin s |
EP0934293A1 (en) * | 1996-07-30 | 1999-08-11 | Arris Pharmaceutical Corporation | Novel compounds and compositions for treating diseases associated with tryptase activity |
DE19817461A1 (de) * | 1998-04-20 | 1999-10-21 | Basf Ag | Neue substituierte Benzamide, deren Herstellung und Anwendung |
JP2002538151A (ja) | 1999-03-02 | 2002-11-12 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | カテプシンの可逆的インヒビターとして有用な化合物 |
DE60003702T2 (de) * | 1999-09-13 | 2004-04-22 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | Heterocyclische verbindungen als reversible inhibitoren von cysteinproteasen |
US6420364B1 (en) | 1999-09-13 | 2002-07-16 | Boehringer Ingelheim Pharmaceuticals, Inc. | Compound useful as reversible inhibitors of cysteine proteases |
CA2387805C (en) | 1999-11-18 | 2012-08-28 | Corvas International, Inc. | Nucleic acids encoding endotheliases, endotheliases and uses thereof |
US7700341B2 (en) | 2000-02-03 | 2010-04-20 | Dendreon Corporation | Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
ATE324372T1 (de) | 2000-08-14 | 2006-05-15 | Ortho Mcneil Pharm Inc | Substituierte pyrazole |
RU2317988C2 (ru) | 2000-08-14 | 2008-02-27 | Орто-Макнейл Фармасьютикал, Инк. | Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s |
PT1309591E (pt) | 2000-08-14 | 2007-04-30 | Ortho Mcneil Pharm Inc | Pirazoles substituídos |
US7332494B2 (en) | 2000-08-14 | 2008-02-19 | Janssen Pharmaceutica, N.V. | Method for treating allergies using substituted pyrazoles |
US6579896B2 (en) | 2000-09-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Method for treating allergies using substituted pyrazoles |
WO2002048097A1 (en) * | 2000-12-12 | 2002-06-20 | Corvas International, Inc. | Compounds, compositions and methods for treatment of parasitic infections |
JP2004523506A (ja) | 2000-12-22 | 2004-08-05 | アクシス・ファーマシューティカルズ・インコーポレイテッド | カテプシン阻害剤としての新規な化合物と組成物 |
US7030116B2 (en) | 2000-12-22 | 2006-04-18 | Aventis Pharmaceuticals Inc. | Compounds and compositions as cathepsin inhibitors |
EP1436255A1 (en) * | 2001-09-14 | 2004-07-14 | Aventis Pharmaceuticals, Inc. | Novel compounds and compositions as cathepsin inhibitors |
WO2003024923A1 (en) * | 2001-09-14 | 2003-03-27 | Axys Pharmaceuticals, Inc. | Sulfonamide compounds as protease inhibitors |
KR20050044497A (ko) | 2001-11-14 | 2005-05-12 | 아벤티스 파마슈티칼스 인크. | 올리고펩티드 및 카텝신 s 억제제로서 이를 포함하는조성물 |
GB0311406D0 (en) * | 2003-05-17 | 2003-06-25 | Queen Mary & Westfield College | Substituted phosphonate fluorescent sensors,and use thereof |
SG191591A1 (en) | 2008-05-21 | 2013-07-31 | New World Lab Inc | Selective caspase inhibitors and uses thereof |
WO2010133000A1 (en) | 2009-05-21 | 2010-11-25 | New World Laboratories Inc. | Selective caspase inhibitors and uses thereof |
US8895497B2 (en) | 2009-12-04 | 2014-11-25 | Dcb-Usa, Llc | Cathepsin S inhibitors |
EP2697246B1 (en) | 2011-04-15 | 2018-03-07 | Genesis Technologies Limited | Selective cysteine protease inhibitors and uses thereof |
KR101309578B1 (ko) * | 2011-05-06 | 2013-09-17 | 연세대학교 산학협력단 | 시스테인 프로테아제 선택성을 갖는 다이타이로신 화합물 및 이를 이용한 시스테인 프로테아제의 검출방법 |
KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
US20200361967A1 (en) * | 2018-01-19 | 2020-11-19 | Osaka Soda Co., Ltd. | Organosilicon compound and rubber composition comprising the same |
EP3553521A1 (en) * | 2018-04-12 | 2019-10-16 | Koninklijke Philips N.V. | Gingivitis diagnostic methods, uses and kits |
-
1996
- 1996-03-21 AU AU53674/96A patent/AU713492B2/en not_active Ceased
- 1996-03-21 PL PL96322409A patent/PL322409A1/xx unknown
- 1996-03-21 CA CA002216151A patent/CA2216151A1/en not_active Abandoned
- 1996-03-21 JP JP8529509A patent/JPH11503417A/ja active Pending
- 1996-03-21 CZ CZ972981A patent/CZ298197A3/cs unknown
- 1996-03-21 NZ NZ305626A patent/NZ305626A/xx unknown
- 1996-03-21 EP EP96910499A patent/EP0817778A1/en not_active Withdrawn
- 1996-03-21 CN CN96193951A patent/CN1071751C/zh not_active Expired - Fee Related
- 1996-03-21 WO PCT/US1996/003844 patent/WO1996030353A1/en not_active Application Discontinuation
- 1996-03-21 KR KR1019970706665A patent/KR19980703261A/ko not_active Application Discontinuation
- 1996-03-22 MY MYPI96001076A patent/MY113489A/en unknown
- 1996-03-22 ZA ZA962336A patent/ZA962336B/xx unknown
- 1996-03-24 IL IL11763896A patent/IL117638A0/xx unknown
- 1996-04-12 TW TW085104392A patent/TW470750B/zh active
-
1997
- 1997-09-23 NO NO19974403A patent/NO311573B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MY113489A (en) | 2002-03-30 |
TW470750B (en) | 2002-01-01 |
WO1996030353A1 (en) | 1996-10-03 |
NZ305626A (en) | 2000-01-28 |
CN1184472A (zh) | 1998-06-10 |
EP0817778A1 (en) | 1998-01-14 |
NO311573B1 (no) | 2001-12-10 |
AU713492B2 (en) | 1999-12-02 |
JPH11503417A (ja) | 1999-03-26 |
CN1071751C (zh) | 2001-09-26 |
AU5367496A (en) | 1996-10-16 |
NO974403D0 (no) | 1997-09-23 |
CZ298197A3 (cs) | 1998-03-18 |
ZA962336B (en) | 1996-07-31 |
NO974403L (no) | 1997-11-17 |
CA2216151A1 (en) | 1996-10-03 |
IL117638A0 (en) | 1996-07-23 |
KR19980703261A (ko) | 1998-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA962336B (en) | Reversible protease inhibitors | |
PL326508A1 (en) | Protease inhibitors | |
ZA964751B (en) | Reversible cysteine protease inhibitors | |
IL131661A0 (en) | Protease inhibitors | |
HU9601508D0 (en) | Dp-iv-serine protease inhibitors | |
PL336589A1 (en) | Serinic protease inhibitors | |
EP0744948A4 (en) | PROTEASE INHIBITORS | |
HUP9903863A3 (en) | Metalloproteinase inhibitors | |
PL328307A1 (en) | Serinic protease inhibitors | |
PL336856A1 (en) | Protease inhibitors | |
ZA983841B (en) | Protease inhibitors | |
IL132629A0 (en) | Protease inhibitors | |
PL328875A1 (en) | Serinic protease inhibitors | |
ZA988479B (en) | Protease inhibitors | |
PL328223A1 (en) | Aspartil protease inhibitors | |
HUP9802764A3 (en) | Guanidino protease inhibitors | |
ZA988064B (en) | Protease inhibitors | |
ZA961225B (en) | Serine protease inhibitors | |
EP0975612A4 (en) | PROTEASE INHIBITORS | |
GB9500946D0 (en) | Protease inhibitors | |
GB9520761D0 (en) | Protease inhibitors | |
GB2318353B (en) | Metalloproteinase inhibitors | |
GB9420277D0 (en) | Protease inhibitors | |
GB9513320D0 (en) | Metalloproteinase inhibitors | |
GB9503754D0 (en) | Metalloproteinase inhibitors |